Form 8-K - Current report:
SEC Accession No. 0001640334-24-001537
Filing Date
2024-10-16
Accepted
2024-10-16 17:18:01
Documents
25
Period of Report
2024-10-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm   iXBRL 8-K 43409
2 EX-1.1 lxrp_ex11.htm EX-1.1 47852
3 EX-4.1 lxrp_ex41.htm EX-4.1 97241
4 EX-4.2 lxrp_ex42.htm EX-4.2 98496
5 EX-5.1 lxrp_ex51.htm EX-5.1 13972
6 EX-10.1 lxrp_ex101.htm EX-10.1 232888
7 EX-99.1 lxrp_ex991.htm EX-99.1 11776
8 EX-99.2 lxrp_ex992.htm EX-99.2 11670
14 lxrp_ex51img1.jpg GRAPHIC 7105
15 lxrp_ex51img2.jpg GRAPHIC 7105
16 lxrp_ex11img2.jpg GRAPHIC 8933
  Complete submission text file 0001640334-24-001537.txt   876897

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20241014.xsd EX-101.SCH 6120
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20241014_lab.xml EX-101.LAB 16212
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20241014_cal.xml EX-101.CAL 898
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20241014_pre.xml EX-101.PRE 11893
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20241014_def.xml EX-101.DEF 4149
27 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_8k_htm.xml XML 5576
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-39874 | Film No.: 241375381
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)